Brief: Kancera: Agreement On Development Of HDAC6 Inhibitors Terminated

Novakand Pharma AB

01/12/2020 13:19

Dec 1 (Reuters) - Kancera AB  KANC.ST :
    * AGREEMENT ON DEVELOPMENT OF HDAC6 INHIBITORS TERMINATED
    * AGREEMENT TERMINATION DOES NOT AFFECT CO'S OPERATIONAL
PLAN OR
CAPACITY TO DRIVE PROJECTS FORWARD

Source text for Eikon:  ID:nMFN1T6y7P 
Further company coverage:  KANC.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))